Polaryx Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for rare, pediatric lysosomal storage diseases (LSDs). The company serves patients with LSDs through a multi-modal approach that includes small molecule therapies and gene therapy.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.